KARDIOLOGIA POLSKA, cilt.71, sa.10, ss.1036-1041, 2013 (SCI-Expanded, Scopus)
Background: Right ventricular (RV) dysfunction complicates advanced left ventricular (LV) heart failure (HF) and contributes to a poor prognosis. Levosimendan is a positive inotropic agent improving cardiac contractility without increasing myocardial oxygen consumption in HF.